Arbutus Biopharma Corp(ABUS-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | -0.08 | -0.09 | -0.39 | -0.34 |
| Number of Estimates | 2 | 2 | 3 | 3 |
| High Estimate | -0.07 | -0.07 | -0.38 | -0.30 |
| Low Estimate | -0.09 | -0.10 | -0.40 | -0.42 |
| Prior Year | -0.12 | -0.10 | -0.44 | -0.39 |
| Growth Rate Est. (year over year) | +33.33% | +10.00% | +11.36% | +12.82% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $-0.10 | $-0.11 | $-0.10 | $-0.12 |
| Estimate | $-0.10 | $-0.10 | $-0.10 | $-0.12 |
| Difference | unch | -0.01 | unch | unch |
| Surprise | unch | -10.00% | unch | unch |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.60
3 Mths Ago5
4.60
2 Mths Ago5
4.60
1 Mth Ago5
4.60
Current5
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 5 | 5 | 5 | 5 |
4 | 4 | 4 | 4 | |
| Holds | 1 | 1 | 1 | 1 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell